PROCTER & GAMBLE HEALTH
|
The Current P/B Ratio of PROCTER & GAMBLE HEALTH is 16.15.
| Share Price | ₹5,054.2 | Oct 26,2026 |
| Market Cap | ₹8,390.0 Cr | |
| Book Value | ₹519.5 Cr | Mar2026 - Standalone Results |
| Price/Book | 16.15x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of PROCTER & GAMBLE HEALTH
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹8,390.0 Cr] as on Oct 26,2026
(/) Book Value [ ₹519.5 Cr] based on Mar2026 - Standalone Results
(=) P/B Ratio [ 16.15x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '16.15 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/B Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PB (Price/Book ) ratio chart of PROCTER & GAMBLE HEALTH
PB Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/b ratio for fiscal years ending Mar2026 to Jun2022 averaged 14.07x.
- PROCTER & GAMBLE HEALTH 's operated at median p/b ratio of 15.33x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/b ratio peaked in Mar2025 at 16.04x.
- PROCTER & GAMBLE HEALTH 's p/b ratio hit its five-year low in Jun2022 of 11.41x.
How does PROCTER & GAMBLE HEALTH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 519.45 | 16.15 | 8,390.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.00 | 418,204.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 14.37 | 240,780.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 20.72 | 173,828.0 |
| CIPLA LTD | 34,369.40 | 3.18 | 109,305.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.88 | 108,759.0 |
| MANKIND PHARMA LTD | 16,252.60 | 5.85 | 95,083.0 |
| LUPIN LTD | 22,384.10 | 3.98 | 89,172.1 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.26 | 115,521.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.41 | 91,485.1 |
| LAURUS LABS LTD | 5,275.08 | 21.10 | 111,304.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs PROCTER & GAMBLE HEALTH 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.41x |
| Max industry PB | 21.10x |
| Median industry PB | 5.00x |
| Average industry PB | 9.08x |
You may also like the below Video Courses